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In Vitro Immunosuppresshe Effects of FKS06 in 
Combination \\'ith Other Drugs 
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T HE 11\ VITRO immunosuppressive ac-tivity of the newl) described drug 
FK506 (FK) is several hundredfold greater 
than that of cyclosporine A (CsA)u The 
strong inhibitory effect of FK can be demon-
strated in primary mixed lymphocyte culture 
(MLC) and in secondary proliferation of 
alloreactive T cells generated from mixed 
lymphocyte response (MLR) cultures or pro-
pagated from organ transplant biopsy speci-
mens. I .) The inhibitory effect of FK on lym-
phocyte proliferation appears to be mediated 
by blocking of interleukin 2 (IL2) release. I·] 
Our in vitro studies showed a synergism 
between the immune suppressive effects of FK 
and CsA] on both primary and secondary T 
lymphocyte activation. In addition. effective 
prolongation of graft survival in dogs and rats 
was achieved by using combination therapy 
with low doses of FK. CsA. and steroids.-·5 
We describe here the in vitro immunosup-
pressive effects on human MLR proliferation 
of combinations of low doses of FK. CsA. and 
azathioprine (Aza). These studies may have 
clinical application in that nontoxic low doses 
of drug combinations may provide effective 
immunosuppressive treatment. 
MATERIALS AND METHODS 
MLC 
Human peripheral blood lymphocytes were isolated 
from heparinized blood b) the Ficoll-Hypaque gradient 
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Drug Sources 
FK was kindl) supplied by FUJisa ... a Pharmaceutical 
Co. Osaka. Japan. as a crystalline powder. It "'il 
dissolved in methanol and kept at - 4°C. Ala was pur. 
chased from Sigma Chemical Co. St Louis. and "'il 
dissolved in a minimal amount of dilute !'iaOH, CsA"'il 
obtained from Sandoz (Hano\'er, NJ) and was dissolVed 
in ethanol. 
Dose Effect of FK. CsA. and A:a on 
Lymphocyte Proliferation 
The immunosuppressive effect of FK. CsA. and Aza on 
M LR reactivity was measured at different concentrations 
of drugs ranging from 0.01 to 1.000 ng/mL The resulli 
were cltpressed as percent inhibition by using the follo\ll. 
ing formula: percent inhibition - (I - (cpm with drugs/ 
cpm without drugs») x 100. 
RESULTS 
Effect of Lok' Doses of FK and CsA on MLR 
We have previously shown that FK induced 
a significant inhibition of the MLR and that 
this effect was observed at concentrations of 
drug that were 500-fold lower than those of 
CsA.2.) Combinations of low doses of FK and 
CsA are illustrated in Fig 1. It may be seen 
that a significant inhibition of 60'k was 
achieved by adding to the lymphocyte culture 
FK and CsA at concentrations of 0.05 and 10 
ng/mL. respectively. On the other hand. at 
these low concentrations neither drug was 
effective. Our data also suggest that the syner-
gistic effect between CsA and FK is primarily 
dependent on the concentration of the latter. 
For instance. the addition of 0.05 ng/mL of 
FK to lymphocyte cultures in the presence of 
various concentrations of CsA (I to 10 ng/ 
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MBINATION WITH OTHER DRUGS 
_"" JH CO 
If 
1. Effect of low doses of fie: end CsA on MlR. 
fill ns of MlR in the pre.ence of different concen· ~ of FK (0.05 end 0.025 ng/mL) were 2% end O'lb, 
:::::;:iveIY. (." CsA • FK 0.05 ng/ml: ([:Jl. CsA ~ FK 
e,Gl5ng/ml; (01. CIA. 
-,U induced a significant inhibition of MLR 
(.c3~ to 6l9(). On the other ha nd, a twofold 
,tduction of the FK dose (0.025 ng/mL) 
,dded to the same concentrations of CsA (1 to 
10 ng/mL) greatly diminished the synergistic 
inhibitory effect of these drug combina tions . 
Effect of Lo'w Doses of FK and A:a on M LR 
Significant inhibition of the MLR (>50%) 
.'as demonstrated in the presence of FK at 
concentrations that were at least I 06• fold 
lower than those of Aza (data not shown), The 
inhibitory effect of the combination of low 
doses of FK and Ala was tested on primary 
MLR proliferation. The two doses of FK (0.05 
and 0.025 ng/mL) that alone showed no inhi· 
bition of MLR were added to lymphocyte 
cultures that contained Aza (I to 0.1 ~g/mL). 
Maximum inhibitory effect was achieved by 
combining FK with Ala at concentration of 
0.05 ng/mL and I ~g/mL. respectively (Fig 
2). The synergism between FK and Ala was 
mostly affected by the concentration of FK in 
the mixture, as previously demonstrated for 
the FK-CsA combination (Fig 2). 
These findings suggest that certain low 
concentrations of FK and CsA or FK and Aza 
have similar synergistic inhibitory effects on 
primary T lymphocyte activation as measured 
by the MLR test. 
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Fig 2. Effect of low do.e. of FK end Aze on MLR_ 
Inhibitions of MlR in the presence of different concen-
tr.tions of FK (0.05 end 0.01 ng/mLl were 7% end 4'lb. 
respectively. 1." Au - FK 0.05 ng/ml; (0). Az • .. FK 
0.01 ng/ml; (0), Aze_ 
DISCUSSION 
These results extend our original observa· 
tions that low doses of FK and CsA exhibit a 
synergistic immunosuppressive effect on Iym· 
phocyte proliferation.) This synergism was 
observed not only between FK and CsA but 
also in the combination of low doses of FK and 
Aza, 
Significant synergism was detected in the 
presence of the maximum FK concentration 
that showed no or minimal immunosuppres· 
sive effect on lymphocyte proliferation. The 
same pattern was observed for both combina· 
tions, FK·CsA and FK·Ala. which suggests 
that the presence of a certain amount of FK 
was essential in achieving a significant syner· 
gistic effect. 
The effectiveness of any drug therapy must 
consider the side effects that seem to be 
associated with higher concentrations of the 
drug. A clear advantage of using combination 
of low doses of drugs. FK·CsA or FK·Aza to 
prolong transplant survival is that there would 
be a reduction of these complications. 
Recently i.was shown that combination ther· 
apy with low doses of FK, CsA, and steroids 
may effectively induce prolongation of car· 
diac allografts in rats and kidney allografts in 
dogs.' 
The mechanism of synergism between FK 
and other drugs is not well understood. CsA 
t 
I 
• r 
and A73 exhibit their immunosuppressive 
effccl~ on I~ mrhoc)tc proliferation through 
difTerellt mechanisms. The inhibitory effect of 
C~A is mediated by inhibition of I L2 rc1ca~e. 
.... hercas A7a interferes \\ith D;";A synthesis 
of all di\·iding cells. Ho\\cver. both drug~ sho\\ 
a similar synergistic efTect when used in low 
doses in combination \\ith FK. Recent studies 
have sho\\n that cellular uptake of 3H·CsA is 
enhanced when periphera I blood lymphocytes 
are incubated in a medium containing FK.B 
These findings may indicate that the syner· 
gism bWloeen FI\ and Cs.t\ might be relate<! 
Iymphocytc membrane.blnding of these dru to 
Studies arc current" initiated to ime't' &A 
• 3 Iga~ 
the influence of FI\ on the uptake of Oth 
drugs such as A7a and steroid~. er 
Furthermore. the dC\'elopment of a Sen· 
live test to qua ntitate t he a mou nt of FK on t~ 
membrane \. tha~ bound intracellularl), 'Will 
enable us to obtaIn a better understanding of 
the mechanism of synergism h,et\\cen FK and 
other drugs. 
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